Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC Gains 6%; BSE HEALTHCARE Index Up 0.3%
Tue, 15 Oct 12:13

FDC Gains 6%; BSE HEALTHCARE Index Up 0.3%Image source: Eoneren/www.istockphoto.com

FDC share price has zoomed 6% and is presently trading at Rs 563.0.

Meanwhile, the BSE HEALTHCARE index is at 44,757.8 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are Jubilant Pharmova (up 4.0%) and POLY MEDICURE (up 3.8%).

Natco Pharma (down 2.5%) and GLAND PHARMA (down 1.4%) are among the top losers today.

Over the last one year, FDC has moved up from Rs 375.3 to Rs 563.0, registering a gain of Rs 187.7 (up 50.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,152.0 to 44,757.8, registering a gain of 59.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 187.4%), Glenmark Pharma (up 132.8%) and SUVEN PHARMACEUTICALS (up 110.1%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,850.2 (down 0.1%).

The top losers among the BSE Sensex today are Bajaj Finance (down 1.9%) and M&M (down 1.6%). The most traded stocks in the BSE Sensex are Tata Steel and Reliance Ind..

In the meantime, NSE Nifty is at 25,071.9 (down 0.2%). Bajaj Auto and Wipro are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,473.1 to 81,850.2, registering a gain of 15,377.2 points (up 23.1%).

FDC Financial Update...

FDC net profit grew 8.4% YoY to Rs 1,190 million for the quarter ended June 2024, compared to a profit of Rs 1,098 million a year ago. Net sales rose 19.0% to Rs 6,383 million during the period as against Rs 5,364 million in April-June 2023.

For the year ended March 2024, FDC reported 57.4% increase in net profit to Rs 3,051 million compared to net profit of Rs 1,938 million during FY23. Revenue of the company grew 8.9% to Rs 19,429 million during FY24.

The current Price to earnings ratio of FDC, based on rolling 12 month earnings, stands at 29.2.


Equitymaster requests your view! Post a comment on "FDC Gains 6%; BSE HEALTHCARE Index Up 0.3%". Click here!